文献速递关节外科

全关节置换术后一般健康不良事件的发生时间是什么

What Is the Timing of General Health Adverse Events That Occur After Total Joint Arthroplasty?
PubMed 文献 · Clin Orthop Relat Res · 2017-01-01

基于美国外科医师学会国家手术质量改进计划2005至2013年124657例初次全髋或全膝关节置换患者的回顾性数据库分析,描述了八种不良事件的中位诊断日及出院后发生比例。结果显示心肌梗死、肺栓塞等急性事件可能发生在出院后,手术部位感染和脓毒症发生较晚,全膝关节置换后肺栓塞和深静脉血栓发生早于全髋关节置换。

要点

  • 八种不良事件中位诊断日从卒中第2天到手术部位感染第17天不等,手术部位感染和脓毒症在30天末发生率仍高。
  • 全膝关节置换后肺栓塞中位第3天vs全髋关节置换第5天,深静脉血栓第5天vs第13天,均P<0.001。
  • 出院后发生比例:心肌梗死34%、卒中36%、肺栓塞36%、肺炎40%、深静脉血栓60%、尿路感染68%、脓毒症68%、手术部位感染95%。

核心结论

  • 随着全关节置换术后住院时间持续缩短,心肌梗死和肺栓塞等急性及立即危及生命的事件可能发生在出院后,需谨慎对待。
  • 手术部位感染和脓毒症的发生时间提示,即使ACS-NSQIP提供的30天随访也可能不足以研究最晚发生的不良事件。
  • 肺栓塞和深静脉血栓在全膝关节置换后倾向于比全髋关节置换后更早发生,应指导这些手术患者的临床监测。
  • 仅住院数据库(如全国住院患者样本)可能遗漏很大比例的术后不良事件,削弱许多已发表研究的结论。

研究设计与样本

  • 回顾性数据库分析,筛选美国外科医师学会国家手术质量改进计划(ACS-NSQIP)2005至2013年所有初次全髋关节置换和初次全膝关节置换患者,研究人群124657例。
  • 对八种不良事件分别确定诊断中位术后日、诊断日四分位距及中间80%范围。
  • 采用多因素Cox比例风险模型检验全膝关节置换与全髋关节置换之间每种不良事件发生时间是否存在差异,并计算出院后与出院前发生不良事件的比例。
  • 证据等级:Level III,治疗性研究。

主要发现

  • 诊断中位日(四分位距;中间80%):卒中2(1-10;1-19)、心肌梗死3(2-6;1-15)、肺栓塞3(2-7;1-19)、肺炎4(2-9;2-17)、深静脉血栓6(3-14;2-23)、尿路感染8(3-16;2-24)、脓毒症10(5-19;2-24)、手术部位感染17(11-23;6-28)。
  • 较晚发生的不良事件(手术部位感染、脓毒症)在术后30天末发生率仍高。
  • 全膝关节置换后肺栓塞发生时间早于全髋关节置换:中位第3天(四分位距2-6)vs第5天(3-17),P<0.001。
  • 全膝关节置换后深静脉血栓发生时间早于全髋关节置换:中位第5天(2-11)vs第13天(6-22),P<0.001。
  • 出院后发生比例:心肌梗死97/283(34%)、卒中42/118(36%)、肺栓塞223/625(36%)、肺炎171/426(40%)、深静脉血栓576/956(60%)、尿路感染958/1406(68%)、脓毒症284/416(68%)、手术部位感染1147/1212(95%)。

临床怎么用

  • 作者认为,全关节置换术后住院时间缩短时需谨慎,因为心肌梗死和肺栓塞等急性及立即危及生命的事件可能发生在出院后。
  • 作者认为,肺栓塞和深静脉血栓在全膝关节置换后比全髋关节置换后更早发生,应指导这些手术患者的临床监测。
  • 作者认为,手术部位感染和脓毒症的发生时间提示ACS-NSQIP的30天随访可能不足以研究最晚发生的不良事件。
  • 作者认为,仅住院数据库可能遗漏很大比例的术后不良事件,削弱使用这些数据库的已发表研究的结论。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite extensive research regarding risk factors for adverse events after total joint arthroplasty (TJA), there are few publications describing the timing at which such adverse events occur. QUESTIONS/PURPOSES: (1) On which postoperative day do certain adverse events occur? (2) What adverse events occur earlier after TKA than after THA? (3) For each adverse event, what proportion occurred after hospital discharge? METHODS: We screened the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) to identify all patients undergoing primary THA and primary TKA between 2005 and 2013, resulting in a study population of 124,657 patients evaluated as part of this retrospective database analysis. For each of eight different adverse events, the median postoperative day of diagnosis, interquartile range for day of diagnosis, and middle 80% for day of diagnosis were determined. Multivariate Cox proportional hazards modeling was used to test whether there is a difference of timing for each adverse event as stratified by TKA or THA. The proportion of adverse events occurring after versus before discharge was also calculated. RESULTS: The median day of diagnosis (and interquartile range; middle 80%) for stroke was 2 (1-10; 1-19), myocardial infarction 3 (2-6; 1-15), pulmonary embolism 3 (2-7; 1-19), pneumonia 4 (2-9; 2-17), deep vein thrombosis 6 (3-14; 2-23), urinary tract infection 8 (3-16; 2-24), sepsis 10 (5-19; 2-24), and surgical site infection 17 (11-23; 6-28). For the later occurring adverse events (surgical site infection, sepsis), the rate of occurrence remained high at the end of the 30-day postoperative period. Timing was earlier in patients undergoing TKA for pulmonary embolism (day 3 [interquartile range 2-6] versus 5 [3-17], p < 0.001) and deep vein thrombosis (day 5 [2-11] versus 13 [6-22], p < 0.001). The proportion of events occurring after discharge for myocardial infarction was 97 of 283 (34%), stroke 42 of 118 (36%), pulmonary embolism 223 of 625 (36%), pneumonia 171 of 426 (40%), deep vein thrombosis 576 of 956 (60%), urinary tract infection 958 of 1406 (68%), sepsis 284 of 416 (68%), and surgical site infection 1147 of 1212 (95%). CONCLUSIONS: As lengths of hospital stay after TJA continue to decrease, our findings suggest that caution is in order because several acute and immediately life-threatening findings, including myocardial infarction and pulmonary embolism, might occur after discharge. Furthermore, the timing of surgical site infection and sepsis suggests that even the 30-day followup afforded by the ACS-NSQIP may not be sufficient to study the latest occurring adverse events. Additionally, both pulmonary embolism and deep vein thrombosis tend to occur earlier after TKA than THA, and this should guide clinical surveillance efforts in patients undergoing those procedures. These findings also indicate that inpatient-only databases (such as the Nationwide Inpatient Sample) may fail to capture a very large proportion of postoperative adverse events, weakening the conclusions of many published studies using those databases. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Bohl DD, Ondeck NT, Basques BA, et al. What Is the Timing of General Health Adverse Events That Occur After Total Joint Arthroplasty? Clin Orthop Relat Res. 2017. PMID: 28054326. doi:10.1007/s11999-016-5224-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。